BioCentury
ARTICLE | Emerging Company Profile

Vineti: Keeping cell therapies on track

How Vineti's GMP-ready platform connects the cell therapy supply chain

May 3, 2019 9:23 PM UTC

Drawing on its experience with CAR T cell therapies, Vineti has developed a cloud-based software platform that standardizes processes and drives down costs in the supply chain for personalized medicines.

According to Vineti Inc. CEO Amy DuRoss, the company was incubated at GE Ventures after an undisclosed company approached the investor in 2014 about a CAR T cell therapy then in clinical trials. ...



Access The Full Article